Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

NAMS recognizes outstanding contributions to the field of women's health, menopause

The North American Menopause Society is pleased to announce the recipients of the Society's 2015 awards that recognize outstanding contributions to the field of women's health and menopause. The recipients will be acknowledged during the NAMS 26th Annual Meeting, in Las Vegas, NV, from September 30 through October 3, 2015.

21 Sep 2015

Study confirms pathogenic role of beta amyloid in dementia as seen in AD and Down syndrome

More than five million Americans are living with Alzheimer's disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid.

18 Sep 2015

Researchers identify protein that regulates neuron growth

An international team of researchers, led by scientists at the National University of Singapore (NUS), has identified a protein that regulates the growth of neurons by transporting key metabolic enzymes to the tips of neural cells.

18 Sep 2015

Researchers receive NIH grant to test novel drug therapy for Alzheimer's dementia

Johns Hopkins University researchers have received an estimated $7.5 million National Institutes of Health grant to clinically test what would be the first treatment to prevent or delay the onset of Alzheimer's dementia.

16 Sep 2015

AgeneBio's HOPE4MCI Phase 3 trial receives support from NIH

AgeneBio, a biopharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, announced today that its HOPE4MCI Phase 3 clinical trial has received support from the National Institutes of Health.

15 Sep 2015

UGA microbiology researchers identify potential mechanism for neurodegenerative diseases

Microbiology researchers at the University of Georgia studying a soil bacterium have identified a potential mechanism for neurodegenerative diseases.

15 Sep 2015

Study shows link between impaired mitochondria, energy failure, and neuronal dysfunction

A new study from the Gladstone Institutes shows for the first time that impairments in mitochondria--the brain's cellular power plants--can deplete cellular energy levels and cause neuronal dysfunction in a model of neurodegenerative disease.

15 Sep 2015

Cautiously-designed combination therapies may attenuate side effects associated with Alzheimer's drugs

BACE1 is the major drug target for Alzheimer's disease, but we know surprisingly little about its normal function in the CNS.

15 Sep 2015

Communicating risk status to at-risk Alzheimer's patients

How would you feel, as a cognitively healthy person, if a doctor said you had high odds of developing Alzheimer's disease within two to five years?

14 Sep 2015

New UCLA study finds novel approach that may help delay declines in health

Why do some people remain healthy into their 80s and beyond, while others age faster and suffer serious diseases decades earlier? New research led by UCLA life scientists may produce a new way to answer that question -- and an approach that could help delay declines in health.

14 Sep 2015

Researchers now have a way to study special proteins linked to different diseases, cancer

Researchers from Northwestern University and Yale University have developed a user-friendly technology to help scientists understand how proteins work and fix them when they are broken. Such knowledge could pave the way for new drugs for a myriad of diseases, including cancer.

11 Sep 2015

Signs of Alzheimer’s found in growth hormone patients

People may be able to contract Alzheimer’s disease during certain medical procedures in the same way that Creutzfeldt-Jakob disease (CJD) is transmitted, suggest researchers from University College London.

10 Sep 2015

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

Allergan plc, today announced that its subsidiaries Forest Laboratories, LLC and Forest Laboratories Holdings, Ltd., along with Adamas Pharmaceuticals, Inc., have entered into a settlement agreement with Amneal Pharmaceuticals LLC and related companies and subsidiaries.

10 Sep 2015

Special issue provides update on mental health diagnosis and treatment of older adults

The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.

10 Sep 2015

World expert panel recommends routine brain health screening for adults older than 70

A panel of world experts in aging convened at Saint Louis University recommended that everyone 70 and older should have their memory and reasoning ability evaluated annually by a doctor or health care provider.

10 Sep 2015

Researchers take new line of approach to combat Alzheimer's disease

Today, more than 5.1 million Americans live with Alzheimer's disease, a devastating type of dementia that plagues memory and thinking. That number is expected to triple in the coming decades. Moreover, according to a 2012 survey, Americans fear Alzheimer's more than any other disease.

10 Sep 2015

Researchers discover potential biomarker for episodic migraine

Researchers may have discovered a new marker found in the blood for episodic migraine, according to a study published in the September 9, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

10 Sep 2015

Women bear six times the cost of AD care compared to men

Women are not only at greater risk of developing Alzheimer's disease (AD) when compared to men; per capita, they also bear six times the cost of AD care that men do, reports a study published today in the journal Women's Health Issues.

10 Sep 2015

HUCBC-derived monocytes diminishes Aβ pathology, improves cognition in AD modeled mice

Alzheimer's disease (AD), which affects an estimated 26 million people worldwide, is the fourth leading cause of death among the elderly and the leading cause of dementia. Predictions are that the number of AD cases will quadruple by 2050.

9 Sep 2015

New $2.8 million NIH grant to help researchers find better treatments for hemorrhagic strokes

Developing better treatments and an improved understanding of the biology behind brain injury from hemorrhagic strokes is the main goal of a three-year $2.8 million grant to the Translational Genomics Research Institute, Phoenix Children's Hospital, and Barrow Neurological Institute.

9 Sep 2015

Alzheimer's Disease News and Research

Further Reading

NAMS recognizes outstanding contributions to the field of women's health, menopause

Study confirms pathogenic role of beta amyloid in dementia as seen in AD and Down syndrome

Researchers identify protein that regulates neuron growth

Researchers receive NIH grant to test novel drug therapy for Alzheimer's dementia

AgeneBio's HOPE4MCI Phase 3 trial receives support from NIH

UGA microbiology researchers identify potential mechanism for neurodegenerative diseases

Study shows link between impaired mitochondria, energy failure, and neuronal dysfunction

Cautiously-designed combination therapies may attenuate side effects associated with Alzheimer's drugs

Communicating risk status to at-risk Alzheimer's patients

New UCLA study finds novel approach that may help delay declines in health

Researchers now have a way to study special proteins linked to different diseases, cancer

Signs of Alzheimer’s found in growth hormone patients

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

Special issue provides update on mental health diagnosis and treatment of older adults

World expert panel recommends routine brain health screening for adults older than 70

Researchers take new line of approach to combat Alzheimer's disease

Researchers discover potential biomarker for episodic migraine

Women bear six times the cost of AD care compared to men

HUCBC-derived monocytes diminishes Aβ pathology, improves cognition in AD modeled mice

New $2.8 million NIH grant to help researchers find better treatments for hemorrhagic strokes

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News